Abstract
In prescription drug markets, the effects of advertising on demand for the drug category and for specific brands have been studied, and the interaction between price and non-price promotions, acting on demand for the drug, is well established. More recently, supply-side decisions such as competitive pricing strategies between rival firms in the same therapeutic category, and the interaction between them and consumer advertising have been examined. The study extends the research on the relationship between competitive pricing strategies and direct-to-consumer advertising (DTCA) by developing and estimating a dynamic model in which sales is influenced by a combination of consumer advertising, detailing, and pricing. The model is estimated using US data from two medical therapeutic categories. One of these datasets has been used in estimation of a static model in a recently published study, and we compare the results of our dynamic model with the static model results. A dynamic model is appropriate for a market where there is a limited period and planning horizon for recovering the costs of drug development before a branded prescription drug loses its patent protection. The relationship between DTCA, detailing, and pricing under different competitive strategies is examined empirically. It is found that the dynamic model can contradict a basic conclusion of a static model, regarding mode of competitive pricing behavior. The relationship between amount and type of DTCA and competitive pricing strategy is as found in previous studies. There are implications for the marketing of pharmaceutical brands during their period of patent protection.
Similar content being viewed by others
References
Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19, 716–723.
Ailawadi, K., Kopalle, P., & Neslin, S. (2005). Predicting competitive response to a major policy change; Combining game-theoretic and empirical analysis. Marketing Science, 24, 12–24.
Amaldoss, W., & He, C. (2009). Direct-to-consumer advertising of prescription drugs: A strategic analysis. Marketing Science, 28, 472–487.
Bala, R. P., & Bhardwaj, P. (2010). Detailing vs. direct-to-consumer advertising in the prescription pharmaceutical industry. Management Science, 56, 148–160.
Chintagunta, P. K., & Desiraju, R. (2005). Strategic pricing and detailing behavior in international markets. Marketing Science, 24, 167–180.
Cyrenne, P. (1997). Price leadership and vertical relationships. Canadian Journal of Economics, 30, 235–245.
Deneckere, R., Kovenock, R. D., & Lee, R. (1992). A model of price leadership based on consumer loyalty. The Journal of Industrial Economics, 40, 147–154.
Dowrick, S. (1986). von Stackelberg and Cournot duopoly: Choosing roles. The RAND Journal of Economics, 17, 251–261.
Fischer, M., & Albers, S. (2010). Patient- or physician-oriented marketing: What drives primary demand for prescription drugs? Journal of Marketing Research, 47, 103–121.
Gal-Or, E. (1985). Information sharing in oligopoly. Econometrica, 53, 329–343.
Hausman, J. A. (1978). Specification tests in econometrics. Econometrica, 46, 1251–1271.
Mintzes, B., Barer, M. L., Kravitz, R. L., Bassett, B., Lexchin, J., Kazanjian, A., Evans, R. G., Pan, R., & Marion, S. A. (2003). How does direct-to-consumer Advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Association Journal, 50, 1704–1715.
Mukherji, P., Janakiraman, R., Dutta, S., & Rajiv, S. (2017). How direct-to-consumer advertising for prescription drugs affects consumers’ welfare: A natural experiment tests the impact of FDA legislation. Journal of Advertising Research, 57, 194–208.
Narayanan, S., Desiraju, R., & Chintagunta, P. K. (2004). Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. Journal of Marketing, 68, 490–505.
Pazgal, A., Soberman, D., & D.A., & Thomadsen, R. (2016). Profit-increasing asymmetric entry. International Journal of Research in Marketing, 33, 107–122.
Pierce, D. A. (1977). Relationships and the lack thereof between economic time series. Journal of the American Statistical Association, 72, 11–26.
Pinto, M. B. (2000). On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychological Reports, 86, 597–607.
Raju, J. S., & Roy, A. (2000). Market information and firm performance. Management Science, 46, 1075–1084.
Rizzo, J. A. (1999). Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. The Journal of Law and Economics, 42, 89–116.
Roth, M. S. (2003). Media and message effects on DTC prescription drug print advertising awareness. Journal of Advertising Research, 43, 180–193.
Roy, A., & Raju, J. S. (2011). The influence of demand factors on dynamic competitive pricing strategy: An empirical study. Marketing Letters, 22, 259–281.
Roy, A., Kim, N., & Raju, J. S. (2006). Assessing new empirical industrial organization (NEIO) methods: The cases of five industries. International Journal of Research in Marketing, 23, 369–383.
Roy, A., Hanssens, D. M., & Raju, J. S. (1994). Competitive pricing by a price leader. Management Science, 40, 809–823.
Roy, A., & Schramm, M. E. (2020). The relationship between competitive pricing and direct-to-consumer advertising: How to manage DTC advertising of Rx drugs in an integrated marketing mix strategy. Journal of Advertising Research, 60(3), 305–323.
Rust, R. T., & Schmittlein, D. C. (1985). A Bayesian cross-validated likelihood method for comparing alternative specifications of quantitative models. Marketing Science, 4, 375–393.
Schramm, M. E., Herbst, J. L., & Mattie, A. (2014). The false claims act: A review and policy recommendations. International Journal of Pharmaceutical and Healthcare Marketing, 8, 295–313.
Sridhar, S., Narayanan, S., & Srinivasan, R. (2014). Dynamic relationships among R&D, advertising, inventory and firm performance. Journal of the Academy of Marketing Science, 2, 277–290.
Tyagi, R. K. (1999). Pricing patterns as outcomes of product positions. The Journal of Business, 72, 135–157.
Villas-Boas, M., & Zhao, Y. (2005). Retailer, manufacturers, and individual consumers: Modeling the supply side in the ketchup marketplace. Journal of Marketing Research, 41, 83–95.
Vuong, Q. H. (1989). Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica, 57, 307–333.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Roy, A. A dynamic model of price competition and promotion in prescription drug markets. Mark Lett 33, 577–591 (2022). https://doi.org/10.1007/s11002-022-09632-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11002-022-09632-9